IP Library Granted Patent US 9,315,807
Granted Patent B1
US 9,315,807 · App. 14/163,885 · Granted Apr 19, 2016

Genome selection and conversion method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,315,807
App. No.
14/163,885
Granted
Apr 19, 2016
Kind
B1
Abstract

The present disclosure provides a method and a kit for selecting and enriching target sequences specific for one or more genomic regions of interest or a subset of a transcriptome using a target-capturing library of probes. The target-enriched library is generated from a random pool of deoxyribonucleic acid (DNA) fragments. The present disclosure provides an efficient and cost-effective method of target selection for targeted genome sequencing, targeted nucleic acid library creation and gene expression studies.

Claims (8)

1. A method for enriching for target nucleic acid sequences from a mixed population of nucleic acid fragments using a blocking RNA, a single labeled target isolation probe and two adaptor molecules, the method comprising:

(a) obtaining a population of nucleic acid fragments;

(b) adding to the population of nucleic acid fragments, the blocking RNA that hybridizes to nontarget repetitive sequences;

(c) denaturing double stranded nucleic acid into single stranded nucleic acids and permitting the blocking RNA to hybridize to the single stranded nucleic acids to form RNA blocked nucleic acid;

(d) hybridizing to the target nucleic acid sequence contained in the RNA blocked nucleic acid, the labeled target isolation nucleic acid probe, wherein the label is positioned between the 5′ end and the 3′ end of the labeled probe;

(e) immobilizing the hybridized nucleic acid of (d) by means of the label and removing unbound material;

(f) removing from the target nucleic acid sequences, non target nucleic acid sequences at the 3′ end and the 5′ end of the nucleic acid fragments of (e) by means of a 5′ single strand specific exonuclease and a 3′ single strand specific exonuclease or a single 3′, 5′ single strand specific exonuclease; and

(g) ligating a 5′ adaptor nucleic acid to the 3′ end of the target nucleic acid sequence and a 3′ adaptor nucleic acid to the 5′ end of the target molecule either in parallel or sequentially and amplifying the target nucleic acid sequence therebetween.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2014
From: RICHARD, CYNTHIA L.
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 032933/0169 →